T1	Encounter 25 37	Hospitalized
E1	Encounter:T1 Location:T69
T2	Assertion 44 52	eligible
E2	Assertion:T2 Asserted:T69
A1	Assertion-Type-Value E2 hypothetical
T3	Age 70 73	Age
E3	Age:T3 Eq-Comparison:E4
T4	Eq-Comparison 74 84	≥ 18 years
E4	Eq-Comparison:T4 Operator:T70 Value:T71 Temporal-Unit:T72
T6	Temporal-Connection 89 100	at the time
E6	Temporal-Connection:T6 Arg2:E7 Arg:E3
A2	Temporal-Connection-Type-Value E6 during
T7	Encounter 104 119	hospitalization
E7	Encounter:T7 
T8	Condition 130 136	sepsis
E8	Condition:T8 Name:T74
T10	Assertion 195 204	suspected
E10	Assertion:T10 Asserted:E11
A3	Assertion-Type-Value E10 possible
T11	Condition 205 214	infection
E11	Condition:T11 Name:T76
T12	Observation 222 232	SOFA score
E12	Observation:T12 Name:T33 Eq-Comparison:E13
T13	Eq-Comparison 236 260	≥2 points above baseline
E13	Eq-Comparison:T13 Operator:T77 Value:T75 Unit:T122
T15	Eq-Comparison 266 274	Received
E15	Eq-Comparison:T15 Temporal-Period:T78
T16	Modifier 275 289	broad-spectrum
E16	Modifier:T16 Modifies:T79
T17	Drug 290 301	antibiotics
E17	Drug:T17 Name:T79 Temporality:E15 Temporality2:E18
T18	Eq-Comparison 302 326	within the last 24 hours
E18	Eq-Comparison:T18 Operator:T80 Temporal-Period:T81 Value:T82 Temporal-Unit:T83
T19	Or 327 329	or
E19	Or:T19 Arg:E17 Arg2:E20
T21	Assertion 370 377	Able to
E21	Assertion:T21 Asserted:E22
A4	Assertion-Type-Value E21 hypothetical
T22	Study 387 397	enrollment
E22	Study:T22 Temporality:E23
T23	Eq-Comparison 398 412	within 4 hours
E23	Eq-Comparison:T23 Operator:T84 Value:T85 Temporal-Unit:T86
T24	Temporal-Connection 413 415	of
E24	Temporal-Connection:T24 Arg:E23 Arg2:E26
A5	Temporal-Connection-Type-Value E24 after
T26	Encounter 420 429	admission
E26	Encounter:T26 Location:T25
T27	Study 456 468	intervention
E27	Study:T27 Temporality:E28
T28	Eq-Comparison 469 483	within 6 hours
E28	Eq-Comparison:T28 Operator:T89 Value:T90 Temporal-Unit:T91
T29	Temporal-Connection 484 486	of
E29	Temporal-Connection:T29 Arg:E28 Arg2:E31
A6	Temporal-Connection-Type-Value E29 after
T31	Encounter 491 500	admission
E31	Encounter:T31 Location:T30
T32	Assertion 526 535	Inability
E32	Assertion:T32 Asserted:E66
A7	Assertion-Type-Value E32 hypothetical
T34	Modifier 547 551	oral
E33	Modifier:T34 Modifies:T94
T35	Or 552 554	or
E34	Or:T35 Arg:E33 Arg2:E25
T36	Procedure 563 569	fluids
E35	Procedure:T36 Name:T94
T38	Allergy 582 589	allergy
E37	Allergy:T38 Name:E36
T39	Condition 595 607	Hyponatremia
E38	Condition:T39 Name:T95
T40	Observation 609 621	serum sodium
E39	Observation:T40 Name:T96 Eq-Comparison:E40
T41	Eq-Comparison 622 632	≤128 mEq/L
E40	Eq-Comparison:T41 Value:T97 Unit:T98 Operator:T125 Per:T99
T42	Condition 639 656	Immunosuppression
E41	Condition:T42 Name:T100
T43	Eq-Comparison 669 676	history
E42	Eq-Comparison:T43 Temporal-Period:T101
T44	Procedure 680 702	solid organ transplant
E43	Procedure:T44 Name:T102 Temporality:E42
T45	Or 703 705	or
E44	Or:T45 Arg:E43 Arg2:E45
T46	Procedure 720 741	ablative chemotherapy
E45	Procedure:T46 Name:T103 Temporality:E30
T47	Drug 743 751	steroids
E46	Drug:T47 Name:T104 Dose:E47
T48	Eq-Comparison 773 782	≥5 mg/day
E47	Eq-Comparison:T48 Value:T105 Unit:T106 Operator:T128 Per:T107
T49	Drug 783 793	prednisone
E48	Drug:T49 Name:T108
T50	Drug 795 810	antimetabolites
E49	Drug:T50 Name:T109
T51	Drug 812 828	anti-TNFα agents
E50	Drug:T51 Name:T110
T52	Drug 830 852	calcineurin inhibitors
E51	Drug:T52 Name:T111
T53	Or 854 856	or
E52	Or:T53 Arg:E51 Arg2:E53
T54	Drug 857 870	mycophenolate
E53	Drug:T54 Name:T112
T55	Procedure 876 883	Surgery
E54	Procedure:T55 Name:T113 Temporality:E56
T57	Eq-Comparison 915 929	within 30 days
E56	Eq-Comparison:T57 Operator:T115 Value:T116 Temporal-Unit:T117
T58	Or 930 932	or
E57	Or:T58 Arg:E54 Arg2:E58
T59	Condition 939 960	intestinal strictures
E58	Condition:T59 Name:T114
T60	Observation 966 984	Do Not Resuscitate
E59	Observation:T60 Name:T118
T61	Observation 986 989	DNR
E60	Observation:T61 Name:T119
T62	Or 991 993	or
E61	Or:T62 Arg:E60 Arg2:E62
T63	Observation 994 1009	Do Not Intubate
E62	Observation:T63 Name:T120
T64	Observation 1011 1014	DNI
E63	Observation:T64 Name:T129
T65	Or 1024 1026	or
E64	Or:T65 Arg:E63 Arg2:E65
T67	Negation 526 535	Inability
E66	Negation:T67 Negates:E35
T68	Encounter-Type 25 37	Hospitalized
A8	Encounter-Type-Value T68 inpatient
T69	Location 61 64	ICU
A9	Location-Value T69 unit
T70	Eq-Operator 74 75	≥
A10	Eq-Operator-Value T70 GTEQ
T71	Eq-Value 76 78	18
T72	Eq-Temporal-Unit 79 84	years
A11	Eq-Temporal-Unit-Value T72 year
T73	Encounter-Type 104 119	hospitalization
A12	Encounter-Type-Value T73 inpatient
T74	Condition-Name 130 136	sepsis
T76	Condition-Name 205 214	infection
T77	Eq-Operator 236 237	≥
A13	Eq-Operator-Value T77 GTEQ
T78	Eq-Temporal-Period 266 274	Received
A14	Eq-Temporal-Period-Value T78 past
T79	Drug-Name 290 301	antibiotics
T80	Eq-Operator 302 308	within
A15	Eq-Operator-Value T80 LTEQ
T81	Eq-Temporal-Period 313 317	last
A16	Eq-Temporal-Period-Value T81 past
T82	Eq-Value 318 320	24
T83	Eq-Temporal-Unit 321 326	hours
A17	Eq-Temporal-Unit-Value T83 hour
T84	Eq-Operator 398 404	within
A18	Eq-Operator-Value T84 LTEQ
T85	Eq-Value 405 406	4
T86	Eq-Temporal-Unit 407 412	hours
A19	Eq-Temporal-Unit-Value T86 hour
T88	Encounter-Type 420 429	admission
A21	Encounter-Type-Value T88 inpatient
T89	Eq-Operator 469 475	within
A22	Eq-Operator-Value T89 LTEQ
T90	Eq-Value 476 477	6
T91	Eq-Temporal-Unit 478 483	hours
A23	Eq-Temporal-Unit-Value T91 hour
T93	Encounter-Type 491 500	admission
A25	Encounter-Type-Value T93 inpatient
T94	Procedure-Name 563 569	fluids
T95	Condition-Name 595 607	Hyponatremia
T96	Observation-Name 609 621	serum sodium
A26	Observation-Type-Value T96 lab
T97	Eq-Value 623 626	128
T98	Eq-Unit 627 630	mEq
T99	Eq-Unit 631 632	L
T100	Condition-Name 639 656	Immunosuppression
T101	Eq-Temporal-Period 669 676	history
A27	Eq-Temporal-Period-Value T101 past
T102	Procedure-Name 680 702	solid organ transplant
T103	Procedure-Name 720 741	ablative chemotherapy
T104	Drug-Name 743 751	steroids
T105	Eq-Value 774 775	5
T106	Eq-Unit 776 778	mg
T107	Eq-Temporal-Unit 779 782	day
A28	Eq-Temporal-Unit-Value T107 day
T108	Drug-Name 783 793	prednisone
T109	Drug-Name 795 810	antimetabolites
T110	Drug-Name 812 828	anti-TNFα agents
T111	Drug-Name 830 852	calcineurin inhibitors
T112	Drug-Name 857 870	mycophenolate
T113	Procedure-Name 876 883	Surgery
T115	Eq-Operator 915 921	within
A29	Eq-Operator-Value T115 LTEQ
T116	Eq-Value 922 924	30
T117	Eq-Temporal-Unit 925 929	days
A30	Eq-Temporal-Unit-Value T117 day
T118	Observation-Name 966 984	Do Not Resuscitate
T119	Observation-Name 986 989	DNR
T120	Observation-Name 994 1009	Do Not Intubate
T5	Modifier 186 191	known
E5	Modifier:T5 Modifies:T76
T9	Or 192 194	or
E9	Or:T9 Arg:E5 Arg2:E10
R1	Equivalent-To Arg1:E11 Arg2:E8	
T33	Observation-Name 222 232	SOFA score
A32	Observation-Type-Value T33 clinical-score
T75	Eq-Value 237 238	2
T14	Eq-Operator 246 251	above
A33	Eq-Operator-Value T14 GT
T122	Eq-Unit 252 260	baseline
A34	Eq-Unit-Value T122 ref-range-normal
T123	And 215 219	with
E14	And:T123 Arg:E11 Arg2:E12
T20	Coreference 330 337	ordered
E20	Coreference:T20 Refers-To:E17
T124	Assertion 342 364	pending administration
E67	Assertion:T124 Asserted:E20
A35	Assertion-Type-Value E67 hypothetical
T25	Location 416 419	ICU
A20	Location-Value T25 unit
T30	Location 487 490	ICU
A24	Location-Value T30 unit
T87	Modifier 555 562	enteric
E25	Modifier:T87 Modifies:T94
T37	Drug 575 581	Inulin
E36	Drug:T37 Name:T92
T92	Drug-Name 575 581	Inulin
T125	Eq-Operator 622 623	≤
A36	Eq-Operator-Value T125 LTEQ
R2	Equivalent-To Arg1:E39 Arg2:E38	
T126	Eq-Comparison 709 716	receipt
E30	Eq-Comparison:T126 Temporal-Period:T127
T127	Eq-Temporal-Period 709 716	receipt
A37	Eq-Temporal-Period-Value T127 past
R3	Equivalent-To Arg1:E43 Arg2:E41	
R4	Equivalent-To Arg1:E45 Arg2:E41	
T128	Eq-Operator 773 774	≥
A38	Eq-Operator-Value T128 GTEQ
R5	Equivalent-To Arg1:E46 Arg2:E41	
R6	Equivalent-To Arg1:E48 Arg2:E41	
R7	Equivalent-To Arg1:E49 Arg2:E41	
R8	Equivalent-To Arg1:E50 Arg2:E41	
R9	Equivalent-To Arg1:E51 Arg2:E41	
R10	Equivalent-To Arg1:E53 Arg2:E41	
T56	Modifier 898 914	intestinal lumen
E55	Modifier:T56 Modifies:T113
T114	Condition-Name 939 960	intestinal strictures
R11	Abbrev-Of Arg1:E60 Arg2:E59	
T129	Observation-Name 1011 1014	DNI
R12	Abbrev-Of Arg1:E63 Arg2:E62	
T66	Observation 1028 1049	no escalation of care
E65	Observation:T66 Name:T121
T121	Observation-Name 1028 1049	no escalation of care
